3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
7
Prostatic Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Anatomic Stage I Breast Cancer AJCC v8
5
Pancreatic Neoplasms
3
Neoplasms
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Renal Cell
2
Carcinoma
2
COVID-19
2
Uveal Melanoma
1
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tonsillar Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Stomatitis
1
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
3
cabozantinib
2
Nivolumab
2
Carboplatin
2
Biopsy
2
relatlimab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Ipilimumab
1
Doxorubicin
1
Cystoscopy
1
Contrast Media
1
Cisplatin
1
Central Venous Catheters
1
CTLA-4 Antigen
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
90 days
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled